CytomX Therapeutics (CTMX) Current Taxes (2017 - 2019)

CytomX Therapeutics has reported Current Taxes for 3 years, with the latest figure at $13.4 million in Q1 2019.

• For the quarter ending Q1 2019, Current Taxes rose 1192.17% year-over-year to $13.4 million; the trailing twelve-month figure through Mar 2019 stood at $13.4 million (up 1192.17% YoY), and the FY2018 full-year result was $13.3 million, up 1333800.0% from the prior year.
• Current Taxes for Q1 2019 stood at $13.4 million, roughly flat from $13.3 million in the prior quarter.
• The five-year high for Current Taxes was $13.4 million in Q1 2019, with the low at $1000.0 in Q4 2017.
• Historically, Current Taxes has averaged $5.9 million across 3 years, with a median of $3.8 million in 2018.
• Annual changes were most pronounced in 2018 — Current Taxes jumped 1333800.0% — and 2019, when it jumped 1192.17%.
• CytomX Therapeutics' Current Taxes stood at $1000.0 in 2017, then jumped by 1333800.0% to $13.3 million in 2018, then grew by 0.26% to $13.4 million in 2019.
• The last three Current Taxes figures came in at $13.4 million (Q1 2019), $13.3 million (Q4 2018), and $5.0 million (Q3 2018), per Business Quant data.